HIGHLIGHTS
- who: . et al. from the Research Institute (IGTP), Spain University of Texas MD Anderson Cancer have published the article: Ef cacy and safety of blinatumomab in children with relapsed/refractory B cell acute lymphoblastic leukemia: A systematic review and meta-analysis, in the Journal: (JOURNAL) of 16/07/2022
- how: The authors developed an information extraction spreadsheet for this project including title first author year of publication study type author country patient characteristics (age sex number of patients) dose in the experimental group follow-up period and outcome indicators. The authors identified 846 potential studies . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.